scPharmaceuticals Inc.【SCPH】 業績推移・財務諸表

(単位:千ドル) 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25
現金同等物 109,462 100,950 95,481 89,660 83,560 79,649 83,744 72,806 75,521 79,042 44,460 72,001 76,019 75,151 79,505 74,450 51,812 41,360 41,471 71,243 75,453 71,350 35,042 46,814 58,447 38,504 91,500 75,700 57,544 40,809
有価証券 - - - - - - - - - 40,469 70,061 33,276 20,490 15,052 5,515 1,010 13,788 14,673 3,897 47,125 40,618 31,527 55,156 29,199 - - - - - -
現金 + 有価証券 109,462 100,950 95,481 89,660 83,560 79,649 83,744 72,806 75,521 119,511 114,521 105,277 96,509 90,203 85,020 75,460 65,600 56,033 45,368 118,368 116,071 102,877 90,198 76,013 58,447 38,504 91,500 75,700 57,544 40,809
売掛金 - - - - - - - - - - - - - - - - - - - - 3,004 1,610 4,175 4,489 5,772 6,116 9,217 11,721 13,854 19,409
商品及び製品 - - - - - - - - - - - - - - - - - - - 1,230 3,621 5,832 7,123 8,840 9,572 15,308 18,107 13,903 14,141 14,573
流動資産合計 111,568 102,965 96,831 91,893 85,811 81,773 84,887 75,647 79,073 122,536 115,688 107,826 99,066 92,492 86,470 78,275 68,226 57,855 47,169 123,308 126,667 113,574 104,339 92,938 76,525 62,631 123,329 105,849 89,353 78,729
有形固定資産 193 225 215 164 154 145 136 127 119 110 102 93 85 77 77 69 66 57 62 54 48 45 39 58 52 47 51 56 52 48
固定資産合計 2,084 2,044 1,988 1,862 1,776 1,686 1,779 1,636 1,415 1,383 1,272 1,222 1,227 1,123 1,061 762 667 1,307 1,231 887 704 597 1,762 1,541 1,929 2,827 1,740 1,670 1,610 1,526
総資産 113,652 105,009 98,819 93,755 87,587 83,459 86,666 77,283 80,488 123,919 116,960 109,048 100,293 93,615 87,531 79,037 68,893 59,162 48,400 124,195 127,371 114,171 106,101 94,479 78,454 65,458 125,069 107,519 90,963 80,255
買掛金 1,519 2,358 1,667 587 221 1,419 542 1,142 652 770 839 1,666 753 531 447 544 445 982 996 1,518 1,626 1,182 3,370 4,001 2,706 5,294 5,003 3,883 4,988 4,026
一年内返済予定の長期借入金 1,265 2,231 3,210 2,811 4,035 4,624 - - - - - 2,408 4,838 7,293 9,777 9,805 9,826 9,851 9,880 - - - - - - - - - - -
流動負債合計 5,800 7,463 7,430 6,673 10,096 13,532 8,104 5,237 4,663 5,929 7,197 9,321 9,648 11,888 14,205 14,846 14,175 15,540 17,176 7,416 7,735 6,635 10,951 13,134 12,318 12,930 15,264 14,876 16,312 20,430
長期借入金 8,222 7,331 6,421 6,826 5,649 5,086 18,842 18,915 18,996 19,076 19,170 16,858 14,515 12,156 9,777 7,354 4,913 2,463 - 36,794 37,252 37,741 38,262 38,811 39,385 39,990 51,099 51,350 51,050 51,200
固定負債合計 9,908 8,954 7,999 8,338 7,093 6,458 20,676 20,681 20,721 19,931 19,948 17,557 15,130 12,684 10,216 7,721 5,325 3,165 114 44,346 43,829 44,109 46,004 44,127 41,570 43,278 79,096 79,323 79,778 81,141
総負債 15,708 16,417 15,429 15,011 17,189 19,990 28,780 25,918 25,384 25,860 27,145 26,878 24,778 24,572 24,421 22,567 19,500 18,705 17,290 51,762 51,564 50,744 56,955 57,261 53,888 56,208 94,360 94,199 96,090 101,571
資本金及び資本剰余金 2 2 2 2 2 2 2 2 2 3 3 3 3 3 3 3 3 3 3 3 4 4 4 4 4 4 5 5 5 5
利益剰余金 -75,748 -85,599 -91,360 -96,459 -105,178 -112,433 -118,640 -129,455 -136,547 -144,842 -153,880 -161,664 -168,766 -175,800 -182,400 -189,698 -197,400 -207,100 -217,300 -226,536 -237,700 -251,900 -267,500 -281,346 -295,500 -312,500 -347,600 -366,494 -386,200 -404,300
株主資本 97,944 88,592 83,390 78,744 70,398 63,469 57,886 51,365 55,104 98,059 89,815 82,170 75,515 69,043 63,110 56,470 49,393 40,457 31,110 72,433 75,807 63,427 49,146 37,218 24,566 9,250 30,709 13,320 -5,127 -21,316
有利子負債合計 9,487 9,562 9,631 9,637 9,684 9,710 18,842 18,915 18,996 19,076 19,170 19,266 19,353 19,449 19,554 17,159 14,739 12,314 9,880 36,794 37,252 37,741 38,262 38,811 39,385 39,990 51,099 51,350 51,050 51,200
純有利子負債 -99,975 -91,388 -85,850 -80,023 -73,876 -69,939 -64,902 -53,891 -56,525 -100,435 -95,351 -86,011 -77,156 -70,754 -65,466 -58,301 -50,861 -43,719 -35,488 -81,574 -78,819 -65,136 -51,936 -37,202 -19,062 1,486 -40,401 -24,350 -6,494 10,391
DEレシオ(%) 9.69 10.79 11.55 12.24 13.76 15.3 32.55 36.82 34.47 19.45 21.34 23.45 25.63 28.17 30.98 30.39 29.84 30.44 31.76 50.8 49.14 59.5 77.85 104.28 160.32 432.32 166.4 385.51 -995.71 -240.2
運転資本 - - - - - - - - - - - - - - - - - - - -